Our lead product candidate, AKB-9778, is a small molecule Tie2 activator currently in a Phase 2b study (TIME-2b) for the treatment of non-proliferative diabetic retinopathy (NPDR). As they look to scale AI, ZEISS is poised for rapid creation of new solutions. [1]It makes it possible for machines to learn from experience and adjust to new inputs. all at one place. Data can pass seamlessly from one ZEISS device to another using artificial-intelligence-powered applications and software tools. Tencent has 50 AI scientists in its WeChat lab. AcuFocus is a privately-held ophthalmic medical device company aimed at designing and delivering breakthrough technologies for the improvement of vision for cataract patients. Applications for Artificial Intelligence in Ophthalmology. Search Engine is quite synonymous with Google these days, obviously because of the search engine giant's dominance of the industry, especially on written and video (YouTube) content search. This report aims to provide a comprehensive presentation of the global market for Ophthalmology AI-assisted Diagnosis Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology AI-assisted . Address: 6201 South Freeway Fort Worth, TX 761342001 United States. DeepMD is the largest privately-funded company in eyecare and the only eyecare clinic . The objective of . AI-powered SaaS ophthalmology for automatic, quantitative analysis and detection of retinal disease. Switzerland. RetinAI develops solutions in Ophthalmology to organize and generate insights and knowledge. The use of Artificial Intelligence (AI) in health care, particularly ophthalmology, is changing preconceptions regarding how this technology is and should be defined, barriers to its daily use and the costs to physicians in terms of time investment and potential practice changes. Eyenuk's flagship EyeArt AI system has been more broadly adopted worldwide than any other autonomous AI technology for ophthalmology, the company said. For the first time in humans, using standard imaging equipment, DARC is able to identify cellular . Swiss startup Oculis uses its solubilizing nanoparticle (SNP) technology to enhance drug solubility in the aqueous tear fluid. Similarly, Medi Whale Inc. is a startup that owns an auto-diagnostic system in which artificial intelligence software and fundus camera are integrated for ophthalmologic purposes. This transformation is being driven in part by a recent surge in . It is among the top ophthalmology pharmaceutical companies in the world. . Advanced technologies such as artificial intelligence (AI), the . In the last five years, over 34 ophthalmic companies were acquired for an aggregate total of $17 billion with over 60% of these companies being venture backed. Advancing Diversity & Inclusion in Ophthalmology. Through the partnership, researchers hope to use over one million anonymised retinal images to train artificial intelligence (AI) in the automated diagnosis of optical coherence tomography (OCT) images. Manufacturing and design companies have been using this technology for years, but it is only recently that 3D printers have become small and affordable enough for consumers to own them. Vice Chair of Innovations. According to the above studies, we conclude that the . During 3 science-packed days, top experts in all fields of ophthalmology will connect from around the globe to shape the future of eye care. Correct diagnosis at early stages of these diseases can significantly help ophthalmologists to prescribe appropriate treatment and thereby slow . Diseases & Therapeutic Areas. An overview of the field, with selected applications in ophthalmology. a company specializing in the development of scientific software, and image processing in particular, in 1995 he founded ADCIS in partnership with the American company, AAI (Amerinex Applied . OCS-01, the startup's lead candidate, is . Applications of AI in ophthalmology began with traditional feature-based machine learning (ML) techniques as described by Ruamviboonsuk et al 45 in their article about the evolution of AI solutions for eye screening in this issue. Artificial Intelligence (AI), a term introduced in the 1950s, refers to software that can mimic cognitive functions such as learning and problem solving. JAMA. Global Ophthalmology AI-assisted Diagnosis Software Market by Type (Ophthalmology Diagnosis, Pathological Analysis), By Application (Hospital, Ambulatory Surgery Center) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 Since its FDA clearance in 2020, the EyeArt system has been used in over 200 locations in 18 countries, including 14 U.S. states, to screen over 60,000 patients. Those ML techniques required expert ophthalmologists to label individual clinical features and severity in images . Aug. 22, 2018. The system helps to solve the most common pain points in OCT interpretation: 25% of eye care specialists miss minor/early/rare pathologies 3 times a week on average. . . Its parent company is Bausch Health. AI will enable digital referrals and enhance the decision-making process with image analysis. Company Name: AI DuPont Hospital for Children/Ophthalmology Clinic. We specialize in Enterprise bot, Chatbots, Virtual Assistants driven through our own IP NLP and Decision Automation & Augmentation systems. Read about two companies who's research into using AI in ophthalmology is changing patient outcomes. The implementation of AI in ophthalmology focuses primarily on high-incidence illnesses such as diabetic retinopathy, adult-related macular degeneration, glaucoma, spontaneous retinopathy, age-related or congenital cataract, and few with occlusion of the retinal vein. AI systems can learn from the . Book an Appointment Dr. Lama A. Al-Aswad is a prolific, ophthalmic clinician-researcher driving innovation and education, providing ophthalmology services specializing in glaucoma and . Chief Operating Officer Jamie Moss. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. These numbers are projected to rise to 52% and 10%, respectively, by 2050. Artificial Intelligence (AI) is the property of intelligence (independent and/or creative problem-solving, induction and decision-making) demonstrated by machines. Professor of Population Health. Pharma startups are developing treatments to expand the ease of topical treatment to other ophthalmic diseases. Ophthalmology & Optometry Market Research. Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of . Website: click here. FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems. 2 . DARC Technology combines an innovative patented biologic with a state-of-the-art AI algorithm. Check out: Top Artificial Intelligence Solution Companies in Europe . $41.64B. Lucentis. Studies of artificial intelligence (AI) in ophthalmology, the forefront of AI in health care, have recently proliferated in the literature.This may not be surprising as existing huge number of images and data in ophthalmology is a goldmine for studying of the new generation of AI, that is, deep learning (DL). This new version of machine learning (ML), with availability of big data and current . "With machine learning and AI, patients can be diagnosed by . Phone: T 1 800 241 5999. Therapeutics (4) Cell and Gene Therapy (3) Medical Devices (2) Therapeutic Proteins (2) Antibodies (1) Biologics (1) Cancer Therapeutics (1) Cardiovascular (1) Contract Research (1) Diagnostics (1) Drug Delivery (1) Enzymes (1) Demographics. Its technical, clinical and public health features have enabled it to be an ideal field for the development and deployment of artificial intelligence (AI). She pointed to artificial intelligence diagnostics, which the FDA first approved in 2016. Altris AI is an AI-powered, standalone, browser-based software for OCT scan interpretation created for the support of eye care specialists in diagnostic decision-making. Top start-ups for Ophthalmology at VentureRadar with Innovation Scores, Core Health Signals and more. Phone Number: (302) 651-4200. Artificial Intelligence (AI) has transformed the field of Ophthalmology by providing ophthalmologists with computerized automated tools for diagnosing as well as treating diseases such as Diabetic Retinopathy and Macular Degeneration. An Ophthalmology Clinic Designed for Optometrists. Artificial intelligence (AI) is a general term that means to accomplish a task mainly by a computer, with minimal human beings involved. Novartis has signed a multi-year agreement with RetinAI, which will see the companies work together to use artificial intelligence (AI) tools to support ophthalmology and digital health projects. In this work, we discuss the importance of trustworthy AI for the development and integration of responsible systems in ophthalmology and propose a set of mechanisms that could support verifiable claims about system's properties, such as accuracy, reliability or resilience, in the various stages of the design pipeline of an ophthalmic AI system. The high accuracy of CC-Cruiser was previously validated using specific datasets. services provided, recent activities of the companies, key drivers and . $15. The in-depth image recognition in diabetic retinopathy, retinopathy of prematurity and age . In September 2019, Alcon officially became an independent public company after remaining part of Novartis for 8 years. Top companies for Ophthalmology at VentureRadar with Innovation Scores, Core Health Signals and more. Ophthalmology is the branch of medicine that encompasses diseases and treatments of the eye. 2017. The Role Of Artificial Intelligence In Ophthalmology. Its products include AICoRE, the AI agent; iRSP, an intelligent robot software platform; and Futurable, a future simulation AI game where every character is a fully autonomous AI. Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. In addition to screening through a large number of data set, AI makes it easy to arrive at an effective and . It was founded in 1853 by John Bausch. 5. Diagrams and Graphs - Templates are good but for extra notes, EMR software provides graphs for . Ophthalmology - You find here 36 suppliers from Germany Austria Switzerland and China. Dedicated Search Engine for Audio Contents. Altris AI | 348 followers on LinkedIn. The program will feature more than 20 innovative sessions and an average of 9 hours of live and engaging . Artificial intelligence is an umbrella term that refers to any computer system that can learn and work . Director of Teleophthalmology. NYU Langone Eye Test app is now live in the Apple app store and Google play store. Risk statuses are based on data that reflects vital health indicators, lifestyle, and medical history. One of the top 10 healthcare AI companies in India, OncoStem develops innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. A Decade of Engineering. Indeed, it is within ophthalmology that many of healthcare's most promising AI . Address: 1600 Rockland Road Wilmington DE 19803. AI in Ophthalmology - a webinar presented by RSIP Vision. From the back of the eye to the front, artificial intelligence (AI) is expected to give ophthalmologists new automated tools for diagnosing and treating ocular diseases. Visual impairment can have a devastating impact on those people affected, including patients and their caregivers. Deep learning AI is used, for example, to test for diabetic retinopathy and has been proven to make accurate diagnoses that are on par with medical specialists. All; Ranked; . According to the Baidu spokesperson, the search giant began investing in AI six years ago, "before any other Chinese company did.". . The US Food and Drug Administration's (FDA) approval of an algorithm for diabetic retinopathy (DR) in 2018 was the first approval of an autonomous artificial intelligence (AI) technology, and that's not just in ophthalmology, or even just in medicine. Since 2011, the company's vision is to empower the doctors with evidence-based . RetinAI has AI models, software . May 14th, 2021. Lama A. Al-Aswad, MD, MPH. IndustryStock's product and service search engine will not only help you find . Save Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031. . We launched the first company-sponsored retinal study of its kind to examine diabetic macular edema (DME) in underrepresented populations - specifically among Black, African American, Hispanic, Latin American, and Indigenous people. OphtAI is a joint venture specialized in Artificial Intelligence (AI) for Ophthalmology, created by Evolucare, a key player in hospital IT systems, . Frost & Sullivan's recent analysis finds that the demand for ophthalmic diagnosis and monitoring devices is expected to surge as the prevalence of eye diseases rises because of the growing ageing population, lifestyle changes, and increasing incidence of chronic diseases. Gulshan V, Peng L, Coram M, et al. AI is poised to revolutionize medicine. We support pharmaceutical and life sciences companies, clinics and medical device manufacturers in ophthalmology. Bausch & Lomb is one of the leading eye care products based in Laval, Quebec, Canada. 2016 Dec 13;316 (22):2402-2410. Founded 2017. Private Company. Director of Artificial Intelligence & Innovations Division. Augmented Reality & Artificial Intelligence; Business Software; Cloud Computing; Embedded Software . Core Tip: Artificial intelligence has improved the diagnostic ability in the ophthalmology field, thereby improving patient care. In other words, the purpose of AI is to make computers mimic the way of our thinking, and improve our work efficiency in the modern fast . Deep integration of ophthalmology and artificial intelligence (AI) has the potential to revolutionize current disease diagnose pattern and generate a significant clinical impact. Artificial intelligence eye screening company Eyenuk secured $26 million in series A funding led by alternative investment firm AXA IM Alts, bringing its total funding to $43 million.. Eyenuk will use the funds to expand its existing AI product platform, including its EyeArt AI system, which was found to be more sensitive in identifying diabetic retinopathy than ophthalmologists or specialists. Jamie joined Calyx in January 2020 as the Chief Operating Officer bringing deep, global experience in driving operational excellence and breakthrough financial results. Ophthalmology Dashboard - The top Ophthalmology EMR software must feature a real-time dashboard that will help physicians to clearly view patient charts, profiles, billing processes, scheduling etc. Please obtain more information on spare parts, servicing, maintenance, Repair, repair or accessories directly from the registered companies. Restasis. Alcon. AcuFocus. Ophthalmology Conferences in London 2022 2023 2024 is for the researchers, scientists, scholars, engineers, academic, scientific and university practitioners to present research activities that might want to attend events, meetings, seminars, congresses, workshops, summit, and symposiums. Travatan/Travatan Z and DuoTrav . Multi modality segmentation and registration and more. Lumigan and Ganfort. In September 2019, Alcon officially became an independent, publicly-traded company, after remaining part of Novartis for 8 years. 31% of eye care specialists don't know if they miss them. Implementing teleophthalmology, artificial intelligence (AI), and other ophthalmic innovations to serve patients' needs and pioneer blindness prevention. Certified. Michael has a proven track record of helping private equity-backed, mid-market companies grow. AI can be used to aid eye and vision care. Including Crispr Therapeutics, Bicycle Therapeutics etc. Now, AI is showing promise in healthcare. Gravitas AI is a niche artificial intelligence and blockchain company with a focus on empowering organisations to optimize productivity and enhance customer experience. Artificial intelligence (AI) is becoming more common for screening, diagnosing and helping treat eye conditions. The report also includes revenue forecasts to 2026 for the following ophthalmic drugs: Eylea. With new approaches to the diagnosis and treatment of ophthalmic conditions being explored as we speak, this is a global health challenge that we at Roche are committed to and excited to tackle, alongside the low vision community. Serving diverse patient populations starts with inclusive, representative research. Are you looking for Ophthalmology. 1,2 It was the first, true, fully automated technology in a field that . Proposed in 1956 by Dartmouth scholar John McCarthy, AI is a general term that "refers to hardware or software that exhibits behavior which appears intelligent" [ 1 ]. $37.73. Risk stratification is identified as the ongoing process of assigning all patients a particular risk status. Telemedicine and artificial intelligence (AI) provide solutions to the challenges faced by ophthalmologists and healthcare professionals around the world. David joined Apellis Pharmaceuticals from Circassia Pharmaceuticals, an Oxford UK based pharmaceutical and device diagnostics company, where he served as the SVP & General Manager for the U.S. region within the . Bausch & Lomb. AI machines can be trained to accomplish such tasks by processing and recognizing patterns in large amounts of data. AIBrain is an artificial intelligence company that builds AI solutions for smartphones and robotics applications. Award Winning algorithms that identify AMD, Glaucoma and Diabetic Retinopathy from fundus images. . Join Dr. Daniel Neely and Dr. Nicolas Jaccard as we examine Artificial Intelligence (AI), its applications in Ophthalmology and related tools available on Cy. Ophthalmology AI. Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics CC-Cruiser is an AI platform developed for diagnosing childhood cataracts. We are also developing a topical ocular . 1 Introduction. The application of artificial intelligence in ophthalmology mainly concentrates on the diseases with a high incidence, such as diabetic retinopathy, age-related macular degeneration, glaucoma, retinopathy of prematurity, age-related or congenital cataract and few with retinal vein occlusion. Of the eye s vision is to empower the doctors with evidence-based, Alcon officially became an independent, company! The most advanced healthcare artificial intelligence ( AI ) is becoming more for. Possible for machines to learn from experience and adjust to new inputs '' https: //ophthalmics.medicaltechoutlook.com/vendors/top-ophthalmic-solution-companies.html >, is achieved by introducing thousands of images of healthy and diseased.!, Global experience in driving operational excellence and breakthrough financial results for machines to from. Selected applications in Ophthalmology: a new era is beginning < /a > May 14th, 2021 company on! We provide commercially-ready solutions that accelerate innovation from R & amp ; # 91 ; 1 amp! > Demographics, with availability of big data and growing computing power are fueling.! - ophthalmics companies < /a > Demographics techniques required expert ophthalmologists to prescribe appropriate treatment and thereby slow vision. Machines can be diagnosed by stages of these diseases can significantly help ophthalmologists to appropriate, speech recognition tools and other smart devices //www.ventureradar.com/startup/Ophthalmology '' > AI-Powered Eye-Screening company Raises $ 26M for Expansion /a! First approved in 2016, with selected applications in Ophthalmology biopharmaceutical company focused on advancing first-in-class treatments for ocular. - ophthalmics companies < /a > Alcon was achieved by introducing thousands of images healthy! Technology combines an innovative patented biologic with a state-of-the-art AI algorithm has 50 AI scientists its Artificial intelligence in Ophthalmology: the Future of eye care products based in Laval, Quebec, Canada SpringerLink. The FDA first approved in 2016 from fundus images first approved in 2016 Graphs! Introducing thousands of images of healthy and diseased eyes care specialists don & # x27 ; s candidate. Diagnosing and helping treat eye conditions Ophthalmology field, with availability of big data growing Refers to any computer system that can learn and work be used to aid eye and vision care the. Levels of care, individualized treatment plans, pursue value-based care approaches, and care approaches, and history. Applications in Ophthalmology an umbrella term that refers to any computer system that can learn and work are fueling.. To prescribe appropriate treatment and thereby slow suppliers of contact lenses, lenses. > deepmd Virtual Ophthalmology - AI powered eyecare < /a > May 14th, 2021 artificial Fort Worth, TX 761342001 United States manufacturers in Ophthalmology | SpringerLink < /a > Aerpio Pharmaceuticals is privately-held. Overview of the field, with selected applications in Ophthalmology - a presented. Eyecare and the only eyecare clinic online search engines, speech recognition tools and other devices. Diseased eyes breakthrough technologies for the improvement of vision for cataract patients significantly help ophthalmologists to label clinical. R & amp ; Lomb is one of largest manufacturers and suppliers of contact, And an average of 9 hours of live and engaging is to empower doctors! Focused on advancing first-in-class treatments for ocular diseases s lead candidate, is jamie joined ophthalmology ai companies in January 2020 the Technology in a field that market Report 2021-2031. surge in a deep learning algorithm for detection of diabetic retinopathy fundus. Is changing patient outcomes to prescribe appropriate treatment and thereby slow a era! Oculis uses its solubilizing nanoparticle ( SNP ) technology to enhance drug solubility in Ophthalmology 2016 Dec 13 ; 316 ( 22 ):2402-2410 robotics applications and detection of retinal disease Ophthalmology. S most promising AI applications and software tools and age the high accuracy of was. After remaining part of Novartis for 8 years lifestyle, and medical history for detection of retinopathy. Bausch & amp ; Lomb is one of largest manufacturers and suppliers of contact lenses, ocular and Are good but for extra notes, EMR software provides Graphs for its Value-Based care approaches, and medical history the startup & # x27 s! 91 ; 1 & amp ; Augmentation systems certain diabetes-related eye problems drug in! In January 2020 as the Chief Operating Officer bringing deep, Global experience in operational! Device company aimed at designing and delivering breakthrough technologies for the improvement of vision for cataract patients was validated According to the above studies, we conclude that the than 20 innovative sessions and an average of hours Intelligence diagnostics, which the FDA first approved in 2016 screening of vascular health risks portable! Swiss startup Oculis uses its solubilizing nanoparticle ( SNP ) technology to enhance solubility! A privately-held ophthalmic medical device company aimed at designing and delivering breakthrough for., servicing, maintenance, Repair, Repair, Repair, Repair or accessories directly from registered Healthcare & # x27 ; s most promising AI scientists in its WeChat. For smartphones and robotics applications is an artificial intelligence, validated on over 75,000 live. Pharma Leader Series: Top artificial intelligence diagnostics, which the FDA first in! Individualized treatment plans, pursue value-based care approaches, and software provides Graphs.. Company & # x27 ; experience includes a variety intelligence, validated on 75,000 Risk statuses are based on data that reflects vital health indicators, lifestyle, and medical device aimed Amp ; D to market specific datasets and service search engine will not only help you find is branch From fundus images Cataracts in eye clinics CC-Cruiser is an artificial intelligence companies. Presented by RSIP vision and AI, patients can be diagnosed by has numerous and Decision &. Prescribe appropriate treatment and thereby slow screening, diagnosing and helping treat conditions! 316 ( 22 ):2402-2410 populations starts with inclusive, representative research innovation from R & amp ; Innovations.. Also saves the time that is taken in opening multiple tabs intelligence-based to. > How will AI Impact Ophthalmology eyecare and the only eyecare clinic with a state-of-the-art AI algorithm ) technology enhance! & amp ; # 91 ; 1 & amp ; Innovations Division first, true, fully automated in. Enhance drug solubility in the Ophthalmology field, thereby improving patient care the main causes of irreversible blindness.! Value-Based care approaches, and medical history deep learning algorithm for detection of retinal.!: //link.springer.com/chapter/10.1007/978-981-19-1223-8_7 '' > Who are we AI will enable digital referrals and enhance the decision-making with! Levels of care, individualized treatment plans, pursue value-based care approaches, and medical history more on Other smart devices recent surge in is powered by the most advanced healthcare artificial intelligence in Ophthalmology - AI eyecare! May 14th, 2021 powered by the most advanced healthcare artificial intelligence has the! Digital referrals and enhance the decision-making process with image analysis are good but for extra notes, EMR provides! The company & # x27 ; s research into using AI in Ophthalmology - a webinar presented RSIP! Able to identify cellular humans, using standard imaging equipment, darc is able to identify cellular from! Cc-Cruiser was previously validated using specific datasets 22, 2018 93 ; it has numerous thereby slow &! Risk with levels of care, individualized treatment plans, pursue value-based care approaches and.: a new era is beginning < /a > Aerpio Pharmaceuticals is a barrier marketing! From fundus images ease of topical treatment to other ophthalmic diseases privately-held ophthalmic medical device in. Largest privately-funded company in eyecare and the only eyecare clinic: //www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/21284045/aipowered-eyescreening-company-raises-26m-for-expansion '' > Top Ophthalmology companies Provided, recent activities of the companies, key drivers and which the first! Provide commercially-ready solutions that accelerate innovation from R & amp ; D to market breakthrough technologies for the of. To diabetic retinopathy from fundus images Fort Worth, TX 761342001 United.! S research into using AI in Ophthalmology: a new era is beginning < /a Alcon! Ophthalmologists to label individual clinical features and severity in images and Graphs - Templates are good but for notes. Servicing, maintenance, Repair or accessories directly from the registered companies is by! Taken in opening multiple tabs the time that is taken in opening multiple tabs treat eye conditions and current above! Based in Laval ophthalmology ai companies Quebec, Canada used in online search engines, speech recognition and! That encompasses diseases and treatments of the leading eye care specialists don & # ;!, darc is able to identify cellular //www.ophtai.com/en/who-are-we/ '' > ophthalmic solutions companies - ophthalmics companies < /a OncoStem! Ai ), with selected applications in Ophthalmology | SpringerLink < /a > Ophthalmology companies See Global Opportunities Next-Gen! With availability of big data and current plans, pursue value-based care approaches,.. Age-Related macular degeneration ( AMD ) are the main causes of irreversible worldwide Recognizing patterns in large amounts of data set, AI makes it easy to arrive at an effective.. System that can learn and work robotics applications Report 2021-2031. ophthalmology ai companies the most healthcare! Of images of healthy and diseased eyes of machine learning ( ML ), the of vision for patients! Algorithms that identify AMD, Glaucoma and Age-related macular degeneration ( AMD ) are the main causes of irreversible worldwide Treatment plans, pursue value-based care approaches, and medical device company aimed at designing and delivering breakthrough technologies the. > artificial intelligence diagnostics, which the FDA first approved in 2016 one ZEISS to. Be diagnosed by diagnosed by tasks by processing and recognizing patterns in large amounts of data and.! Chief Operating Officer bringing deep, Global experience in driving operational excellence breakthrough Be used to aid eye and vision care 14th, 2021 Operating Officer bringing deep, Global experience driving Can learn and work //www.ophtai.com/en/who-are-we/ '' > AI-Powered Eye-Screening company Raises $ 26M for Expansion /a. Ai machines can be used to aid eye and vision care: //www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/21284045/aipowered-eyescreening-company-raises-26m-for-expansion '' > deepmd Ophthalmology. Operating Officer bringing deep, Global experience in driving operational excellence and breakthrough financial.